Are Dovato and Juluca the Same Thing?
Dovato (dolutegravir and lamivudine) and Juluca (dolutegravir and rilpivirine) are combinations of integrase strand transfer inhibitors (INSTIs) and nucleoside analogue reverse transcriptase inhibitors (NRTIs) used as complete regimens to treat human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known substitutions associated with resistance to the individual components of either drug.
Side effects of Dovato and Juluca that are similar include headache and diarrhea.
Side effects of Dovato that are different from Juluca include nausea, insomnia, fatigue, and dizziness.
Both Dovato and Juluca may interact with other antiretroviral medications, dofetilide, metformin, anticonvulsants, St. John's wort, some antacids, cation-containing products or laxatives, sucralfate, buffered medications, and oral calcium and iron supplements (including multivitamins containing calcium or iron).
Dovato may also interact with rifampin and sorbitol.
Juluca may also interact with antimycobacterials, glucocorticoids, H2-receptor antagonists, macrolide or ketolide antibiotics, narcotic analgesics, and proton pump inhibitors (PPIs).
What Are Possible Side Effects of Dovato?
Common side effects of Dovato include:
- fatigue, and
What Are Possible Side Effects of Juluca?
Common side effects of Juluca include:
- diarrhea and
- other antiretroviral medications,
- H2-receptor antagonists,
- St John's wort,
- macrolide or ketolide antibiotics,
- cation-containing products or laxatives,
- buffered medications,
- narcotic analgesics,
- oral calcium and iron supplements (including multivitamins containing calcium or iron),
- and proton pump inhibitors (PPIs).
What Is Dovato?
Dovato (dolutegravir and lamivudine) is a combination of an integrase strand transfer inhibitor (INSTI) and a nucleoside analogue reverse transcriptase inhibitor (NRTI) indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known substitutions associated with resistance to the individual components of Dovato.
What Is Juluca?
Juluca (dolutegravir and rilpivirine) is a combination of a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) and an HIV-1non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Juluca.
What Drugs Interact With Dovato?
Dovato may interact with other antiretroviral drugs for the treatment of HIV-1 infection, dofetilide, metformin, anticonvulsants, rifampin, St. John's wort, cation-containing antacids or laxatives, sucralfate, buffered medications, oral calcium and iron supplements (including multivitamins containing calcium or iron), and sorbitol.
What Drugs Interact With Juluca?
Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Juluca; it is unknown how it would affect a fetus. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Juluca during pregnancy. It is unknown if Juluca passes into breast milk, however, breastfeeding is not recommended due to the potential for HIV transmission.
Resources for Staying Well
Health Solutions From Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
ViiV. Juluca Product Information.